-
1
-
-
0029959130
-
Epidemiology of nosocomial fungal infections
-
Fridkin SK, Jarvis WR. Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 1996; 9: 499-511.
-
(1996)
Clin Microbiol Rev
, vol.9
, pp. 499-511
-
-
Fridkin, S.K.1
Jarvis, W.R.2
-
2
-
-
0031157777
-
The epidemiology of hematogenous candidiasis caused by different Candida species
-
Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997; 24: 1122-8.
-
(1997)
Clin Infect Dis
, vol.24
, pp. 1122-1128
-
-
Abi-Said, D.1
Anaissie, E.2
Uzun, O.3
Raad, I.4
Pinzcowski, H.5
Vartivarian, S.6
-
3
-
-
0031939508
-
National surveillence of nosocomial blood stream infection due to species of Candida other than Candida albicans: Frequency of occurrence and antifungal susceptibility in the SCOPE Program
-
and SCOPE Participant Group
-
Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP and SCOPE Participant Group. National surveillence of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis 1998; 30: 121-9.
-
(1998)
Diagn Microbiol Infect Dis
, vol.30
, pp. 121-129
-
-
Pfaller, M.A.1
Jones, R.N.2
Messer, S.A.3
Edmond, M.B.4
Wenzel, R.P.5
-
4
-
-
78049239332
-
Antifungal agents
-
Murray PR, Pfaller MA, Baron EJ, Jongensen JH, Yolken RH eds, 8th edn. Washington, DC: American Society for Microbiology
-
Arikan S, Rex JH. Antifungal agents. In: Murray PR, Pfaller MA, Baron EJ, Jongensen JH, Yolken RH (eds), Manual of Clinical Microbiology, 8th edn. Washington, DC: American Society for Microbiology, 2003: 1859-68.
-
(2003)
Manual of Clinical Microbiology
, pp. 1859-1868
-
-
Arikan, S.1
Rex, J.H.2
-
7
-
-
33846000052
-
-
Hazen KC, Howell SA. Candida, Cryptococcus and other yeast of medical importance. In: Murray PR, Pfaller MA, Baron EJ, Jongensen JH, Yolken RH, (eds.), Manual of Clinical Microbiology, 8 th edn. Washington, DC: American Society for Microbiology, 2003: 1693-711.
-
Hazen KC, Howell SA. Candida, Cryptococcus and other yeast of medical importance. In: Murray PR, Pfaller MA, Baron EJ, Jongensen JH, Yolken RH, (eds.), Manual of Clinical Microbiology, 8 th edn. Washington, DC: American Society for Microbiology, 2003: 1693-711.
-
-
-
-
8
-
-
78649636937
-
Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast; Approved Standard
-
NCCLS, ISBN 1-56238-328-0, Pennsylvania, NCCLS, 940 West Valley Road, Suit 1400, Wayne
-
NCCLS. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast; Approved Standard. NCCLS Document M27-A (ISBN 1-56238-328-0). Pennsylvania 19087: NCCLS, 940 West Valley Road, Suit 1400, Wayne, 1997.
-
(1997)
NCCLS Document M27-A
, pp. 19087
-
-
-
9
-
-
33845997908
-
-
SPSS for Windows release 11.01 Customer Number 114094. Turkey: Zonguldak, 2001
-
SPSS for Windows release 11.01 Customer Number 114094. Turkey: Zonguldak, 2001.
-
-
-
-
10
-
-
30744462355
-
Results from the ARTEMIS DISK Global Antifungal Surveillance Study: A 6.5 year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing
-
and the Global Antifungal Surveillance Group
-
Pfaller MA, Diekema DJ, Rinaldi MG et al. and the Global Antifungal Surveillance Group. Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5 year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing. J Clin Microbiol 2005; 43: 5848-59.
-
(2005)
J Clin Microbiol
, vol.43
, pp. 5848-5859
-
-
Pfaller, M.A.1
Diekema, D.J.2
Rinaldi, M.G.3
-
11
-
-
18744408760
-
In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period
-
Kucukates E, Erturan Z, Susever S, Yegenoglu Y. In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period. APMIS 2005; 113: 278-83.
-
(2005)
APMIS
, vol.113
, pp. 278-283
-
-
Kucukates, E.1
Erturan, Z.2
Susever, S.3
Yegenoglu, Y.4
-
12
-
-
0033780545
-
Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading
-
Uzun O, Arikan S, Kocagoz S, Sancak B, Unal S. Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading. Diagn Microbiol Infect Dis 2000; 38: 101-7.
-
(2000)
Diagn Microbiol Infect Dis
, vol.38
, pp. 101-107
-
-
Uzun, O.1
Arikan, S.2
Kocagoz, S.3
Sancak, B.4
Unal, S.5
-
13
-
-
33645213833
-
Nosocomial bloodstream infections associated with Candida species in a Turkish University Hospital
-
Yapar N, Uysal U, Yucesoy M, Yuce A. Nosocomial bloodstream infections associated with Candida species in a Turkish University Hospital. Mycoses 2006; 49: 134-8.
-
(2006)
Mycoses
, vol.49
, pp. 134-138
-
-
Yapar, N.1
Uysal, U.2
Yucesoy, M.3
Yuce, A.4
-
14
-
-
33845989236
-
Evaluation of species distribution of yeasts isolated from intensive care units during the four years period
-
Ergon MC, Yucesoy M. Evaluation of species distribution of yeasts isolated from intensive care units during the four years period. Mikrobiyol Bul 2005; 39: 309-18.
-
(2005)
Mikrobiyol Bul
, vol.39
, pp. 309-318
-
-
Ergon, M.C.1
Yucesoy, M.2
-
15
-
-
24744453040
-
Antifungal susceptibility of Candida spp. isolated from pediatric patients: A survey of 4 children's hospitals
-
Zaoutis TE, Foraker E, McGowan KL et al. Antifungal susceptibility of Candida spp. isolated from pediatric patients: a survey of 4 children's hospitals. Diagn Microbiol Infect Dis 2005; 52: 295-8.
-
(2005)
Diagn Microbiol Infect Dis
, vol.52
, pp. 295-298
-
-
Zaoutis, T.E.1
Foraker, E.2
McGowan, K.L.3
-
16
-
-
0026521489
-
Invazive neonatal candidiasis: Comparison of albicans and parapsilosis infection
-
Faix RG. Invazive neonatal candidiasis: comparison of albicans and parapsilosis infection. Pediatr Infect Dis J 1992; 11: 88-93.
-
(1992)
Pediatr Infect Dis J
, vol.11
, pp. 88-93
-
-
Faix, R.G.1
-
17
-
-
0042331368
-
NIAID Mycoses Study Group. A prospective observational study of candidemia: Epidemiology, therapy and influences on mortality in hospitalized adult and pediatric patients
-
Pappas PG, Rex JH, Lee J et al. NIAID Mycoses Study Group. A prospective observational study of candidemia: epidemiology, therapy and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 2003; 37: 634-43.
-
(2003)
Clin Infect Dis
, vol.37
, pp. 634-643
-
-
Pappas, P.G.1
Rex, J.H.2
Lee, J.3
-
18
-
-
0030970811
-
In vitro activity of a new echinocandin, LY303366, compared with those amphotericin B and fluconazole against clinical yeast isolates
-
Uzun O, Kocagoz Cetinkaya Y, Arikan S, Unal S. In vitro activity of a new echinocandin, LY303366, compared with those amphotericin B and fluconazole against clinical yeast isolates. Antimicrob Agents Chemother 1997; 41: 1156-7.
-
(1997)
Antimicrob Agents Chemother
, vol.41
, pp. 1156-1157
-
-
Uzun, O.1
Kocagoz Cetinkaya, Y.2
Arikan, S.3
Unal, S.4
-
19
-
-
15944374266
-
In vitro activity of caspungin compared to amphotericin B, fluconazole and itraconazole against Candida strains isolated in a Turkish University Hospital
-
Arikan S, Sancak B, Hascelik G. In vitro activity of caspungin compared to amphotericin B, fluconazole and itraconazole against Candida strains isolated in a Turkish University Hospital. Med Mycol 2005; 43: 171-8.
-
(2005)
Med Mycol
, vol.43
, pp. 171-178
-
-
Arikan, S.1
Sancak, B.2
Hascelik, G.3
-
20
-
-
0034758558
-
Antifungal susceptibility testing: Practical aspects and current challenges
-
Rex J, Pfaller MA, Walsh TJ et al. Antifungal susceptibility testing: practical aspects and current challenges. Clin Microb Rev 2001; 14: 643-58.
-
(2001)
Clin Microb Rev
, vol.14
, pp. 643-658
-
-
Rex, J.1
Pfaller, M.A.2
Walsh, T.J.3
-
21
-
-
0033942827
-
Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invaziv candidiasis
-
Arthington-Skaggs BA, Warnock DW, Morrison CJ. Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invaziv candidiasis. Antimicrob Agents Chemother 2000; 44: 2081-5.
-
(2000)
Antimicrob Agents Chemother
, vol.44
, pp. 2081-2085
-
-
Arthington-Skaggs, B.A.1
Warnock, D.W.2
Morrison, C.J.3
-
22
-
-
0033003031
-
The trailing end point phenotype in antifungal susceptibility testing is pH dependent
-
Marr AK, Rustad TR, Rex JH, White TC. The trailing end point phenotype in antifungal susceptibility testing is pH dependent. Antimicrob Agents Chemother 1999; 43: 1383-6.
-
(1999)
Antimicrob Agents Chemother
, vol.43
, pp. 1383-1386
-
-
Marr, A.K.1
Rustad, T.R.2
Rex, J.H.3
White, T.C.4
-
23
-
-
70350566491
-
Susceptibility test methods: Yeast and filamentous fungi
-
Murray PR, Pfaller MA, Baron EJ, Jongensen JH, Yolken RH, eds, 8th edn. Washington, DC: American Society for Microbiology
-
Espinel-Ingroff AV, Pfaller MA. Susceptibility test methods: yeast and filamentous fungi. In: Murray PR, Pfaller MA, Baron EJ, Jongensen JH, Yolken RH, (eds), Manual of Clinical Microbiology, 8th edn. Washington, DC: American Society for Microbiology, 2003: 1880-93.
-
(2003)
Manual of Clinical Microbiology
, pp. 1880-1893
-
-
Espinel-Ingroff, A.V.1
Pfaller, M.A.2
|